Diabetes: eye screening (children T2DM)

Indicator type

Network / system level indicator. The indicator would be appropriate to understand and report on the performance of networks or systems of providers.

Rationale

Screening for diabetic retinal disease is effective at detecting unrecognised sight-threatening retinopathy. This indicator aims to help prevent retinopathy in children and young people aged 12 to 18 years with type 2 diabetes through eye screening at least every 2 years.

Source guidance

Diabetes (type 1 and type 2) in children and young people: diagnosis and management. NICE guideline NG18 (2015, updated 2023), recommendations 1.3.76 and 1.3.84

Specification

Numerator: The number of people in the denominator who had a record of eye screening in the previous 24 months.

Denominator: The number of children and young people aged 12 to 18 years with type 2 diabetes.

Calculation: Numerator divided by the denominator, multiplied by 100.

Exclusions: None

Personalised care adjustments or exception reporting should be considered to account for situations where the patient declines, does not attend or if eye screening is not appropriate.

Data source: National Paediatrics Diabetes Audit and National Diabetes Audit Young People with Type 2 Diabetes Dashboard.

Expected population size: The National Paediatric Diabetes Audit for 2023 to 2024 indicates that 0.001% of people in England are children and young people aged 12 plus years with type 2 diabetes: 0.1 per 10,000 patients served by a network. There is no minimum number of patients required for network level indicators. However, consideration should be given to whether the majority of results would require suppression because of small numbers.

ISBN: 978-1-4731-6958-6